OUR PHILOSOPHY

 “Your work is going to fill a large part of your life, and the only way to be truly satisfied is to do what you believe is great work. And the only way to do great work is to love what you do.”
— Steve Jobs, co-founder, Chairman and CEO of Apple Inc.

At Erada Technology Alliance, we love what we do. What could be better than to have the core determination to deliver a product to the world that could save 450 000 lives per year, prevent the long-term debilitating effects on millions of others and save world medical organizations tens of billions of dollars. We are truly satisfied and we believe we are doing great work.

We named our company ‘Erada’ because of one of the definitions of the word – “The will to conquer against all odds”. As an effective team we are determined to focus our ability to tackle the most difficult medical diagnostic problems with courage and innovation. We will succeed in our goal, of that we have no doubt, we have the right people, and organizations do not create success – people do.

We will nurture our people, we will develop close relationships with our supplier partners and we will display the courage and innovation needed to provide a solution the world needs.

Our Vision

Global, large scale screening to eradicate and therefore finally eliminate detectable and treatable infectious diseases, including Malaria. 

Our Mission

• For accurate detection of early asymptomatic infection and disease carriers.
• For accurate diagnosis of acute symptomatic infection.
• To be the Diagnostic Technology of choice to support Vaccination programs and further Vaccination development.
• To be the Diagnostic Technology of choice to support Treatment – and Monitoring of infection.

Dinglasan Malaria Laboratory

Dinglasan Malaria Laboratory established in 2009 as part of the Johns Hopkins Malaria Research Institute prior to its transfer to the University of Florida’s Emerging Pathogens Institute in 2016. 

The lab leverages multi-omics approaches to discover, validate and eventually develop enabling technologies focused on malaria elimination and eradication.

Oasis Diagnostics® Corporation 

Oasis Diagnostics® Corporation founded in 2002 to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics [DNA, RNA and proteins] in the Life Sciences and Diagnostics areas.

The Company is dedicated to meeting the need for more effective screening tools, which may be applied to the early detection of diseases and medical disorders, utilising non-invasive test specimens, particularly oral fluids (saliva).

Fusion Antibodies

Fusion Antibodies  a Contract Research Organisation (CRO) established in 2001 and located in Northern Ireland, UK. Its mission is to enable biopharmaceutical and diagnostic companies to develop innovative products in a timely and cost-effective manner for the benefit of the global healthcare industry.

Montpellier

Award-winning Montpellier is proud to be associated with ERADA Technology Alliance and it’s world-first SALVA Malaria Rapid Test. Montpellier comprise three world-beating marketing services consultancies,  providing ERADA with top drawer public relations capabilities delivered by trained journalists, mouth-watering branding design and creative services and state-of-the-art digital and web services.